If the Pfizer study holds up and the vaccine prove

If the Pfizer study holds up and the vaccine proves out as it gets distributed , that’s fantastic news. And in my mind it doesn’t affect Cytodyn whatsoever. If everything goes perfectly for Pfizer and the logistics required it will impact a select community of high risk people first. And that is globally not just the US per the CEO this morning. That is probably mid to late winter event They have global commits , not just the US. In the meantime our Cd12 study , IMO , will have the enrollment we need for the next interim round by late first week of December add the days to that which are required before the interim and we are in late January. I believe at that point we are a go . Long hauler trial will also be well underway if not finishing up in February. I bought Cytodyn for the HIV and Cancer possibilities and Covid was just an additional value . But I also feel that Leronlimab is going to be needed even more in January than it was this past March based on the accelerating infection numbers in the states and globally..